Hot Stock
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000 % RENDITE!!
Anzeige
ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion
1,94 USD
+3,74 %+0,07
24. Dec, 23:00:00 Uhr,
Nasdaq
Kommentare 259
Summer.76,
22.03.2021 13:07 Uhr
0
Advanced Product Mix Gives Accuray A Shot At Success In U.S. And Overseas
https://seekingalpha.com/article/4415328-advanced-product-mix-gives-accuray-shot-success-in-us-overseas
Summary
• Accuray has a portfolio of radiotherapy products that are generating revenues of ~$380m per annum.
• The company is one of only a few competitors in an exciting growth space and area of unmet need, although its competitors are far bigger and better resourced.
• Its sales have been flat for 2-3 years and share price stagnant for longer, but the stock has been on a bull run over the past 6 months.
• Accuray is pursuing a first-to-market opportunity in China where there is a shortage of radiotherapy treatments, albeit progress has been subject to delays.
• Its fundamentals - i.e. P/S ratio of 1.3x - point to the company being undervalued and its products capable of challenging for a growing market share, in my view.
G
Gast 4541243,
06.03.2021 0:04 Uhr
0
https://www.hackensackmeridianhealth.org/patient-perspectives/living-pain-free-after-trigeminal-neuralgia/
G
Gast 4541243,
28.02.2021 17:16 Uhr
1
https://www.cyberknifemiami.com/earls-story-treating-kidney-cancer-at-cyberknife-miami-saving-both-kidneys/
G
Gast 4541243,
22.02.2021 13:41 Uhr
1
https://m.youtube.com/watch?v=vWm5Qb7W8e4&feature=youtu.be&fbclid=IwAR3reI7VpRYh55D4MODOB91A1U-3NtjQzx9lX6RMP7e_BuI5M60ZHSMfhwo
Summer.76,
20.02.2021 0:02 Uhr
1
Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors
https://www.prnewswire.com/news-releases/accuray-appoints-healthcare-executive-and-physician-byron-c-scott-to-board-of-directors-301231609.html
...announced today the appointment of Byron C. Scott, M.D., MBA to the company's Board of Directors, effective as of February 12, 2021. Dr. Scott brings significant experience as a physician executive with invaluable global expertise in healthcare analytics and technology. ...
Comebacker,
17.02.2021 13:47 Uhr
0
Lönne, klar, nach Covid kommt die in focus - wenn die Leute mal wieder merken, dass es Krebs ist, den man besiegen muss und keine Viren
G
Gast 4541243,
17.02.2021 13:44 Uhr
0
Läuft die so unterm Radar?
G
Gast 4541243,
04.02.2021 17:05 Uhr
0
https://www.royalmarsden.nhs.uk/your-care/treatments/radiotherapy/cyberknife
Summer.76,
03.02.2021 9:36 Uhr
0
👍🍀
G
Gast 4541243,
03.02.2021 9:31 Uhr
0
Danke Summer👍🌞
Summer.76,
02.02.2021 22:36 Uhr
0
https://pub.webull.com/us/news-html/a3ac0d8a1cbf470884c00b77ce8b6083.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en&theme=1
Insider Trends: Insider Purchase Continues Accuray Positive Trend
G
Gast 4541243,
02.02.2021 17:14 Uhr
0
https://www.pmlive.com/pmhub/healthcare_digital_communications/blue_latitude/white_papers_and_resources/the_heavy_toll_of_covid-19_on_cancer_patients?SQ_DESIGN_NAME=2
Summer.76,
27.01.2021 22:38 Uhr
0
Accuray Reports Second Quarter Fiscal 2021 Financial Results
https://www.prnewswire.com/news-releases/accuray-reports-second-quarter-fiscal-2021-financial-results-301216554.html
Second Quarter Fiscal 2021 Summary
Net revenue of $97.5 million including $21.3 million of system revenue in China
Gross orders of $75.4 million, ending backlog of $596.2 million, an increase of 11 percent from December 31, 2019
GAAP operating income of $8.2 million and GAAP net income of $4.8 million compared to GAAP operating income of $3.6 million and GAAP net income of $10.7 million in the prior year second quarter
Adjusted EBITDA grew to $13.5 million from $7.1 million in the prior year second quarter
Received 510(k) FDA clearance for ClearRT Helical kVCT Imaging for the Radixact System
...
G
Gast 4541243,
23.01.2021 17:22 Uhr
0
https://www-radiologyinfo-org.cdn.ampproject.org/c/s/www.radiologyinfo.org/en/amp/stereotactic.html
G
Gast 4541243,
23.01.2021 12:29 Uhr
0
https://pubmed.ncbi.nlm.nih.gov/30847178/
Summer.76,
20.01.2021 20:13 Uhr
0
🍀
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | -15,15 % | |
2 | Lilium Aktie | +268,39 % | |
3 | FREYR BATTERY | ±0,00 % | |
4 | VW Hauptdiskussion | +0,75 % | |
5 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +1,36 % | |
6 | MICROSTRATEGY Hauptdiskussion | +7,81 % | |
7 | Security der nächsten Generation | +22,35 % | |
8 | Auric Minerals Hauptdiskussion | -43,23 % | |
9 | BAYER Hauptdiskussion | -0,63 % | |
10 | MicroStrategy | +7,81 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | -15,15 % | |
2 | Lilium Aktie | +268,39 % | |
3 | FREYR BATTERY | ±0,00 % | |
4 | VW Hauptdiskussion | +0,75 % | |
5 | MICROSTRATEGY Hauptdiskussion | +7,81 % | |
6 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +1,36 % | |
7 | Auric Minerals Hauptdiskussion | -43,23 % | |
8 | BAYER Hauptdiskussion | -0,63 % | |
9 | MicroStrategy | +7,81 % | |
10 | Security der nächsten Generation | +22,35 % | Alle Diskussionen |